Evidence map›Paper›PMID 37723718›Full record

ArticlePhysical review. E2023

Maximum likelihood estimation for reversible mechanistic network models.

Jonathan Larson, Jukka-Pekka Onnela

Abstract read
In one paragraph

Article in Physical review. E, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jonathan LarsonDepartment of Biostatistics, Harvard University, Boston, Massachusetts 02115, USA.
Jukka-Pekka OnnelaDepartment of Biostatistics, Harvard University, Boston, Massachusetts 02115, USA.

Funding

BIOSTATISTICS/EPIDEMIOLOGY TRAINING GRANTS IN AIDST32AI007358 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Michael David Hughes · 1989 to 2026
$12.4M
Training Program in Psychiatric Genetics and Translational ResearchT32MH017119 · NIMH · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KARESTAN C KOENEN, Jukka-Pekka Onnela · 1985 to 2026
$8.9M
Unraveling the Complexities of Risk and Mechanism in CancerR35CA220523 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI QUACKENBUSH, JOHN · 2018 to 2024
$6.0M
Bridging Statistical Inference and Mechanistic Network Models for HIV/AIDSR01AI138901 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Ravi Goyal, Jukka-Pekka Onnela · 2019 to 2026
$3.4M
NCI NIH HHS R35 CA220523NIAID NIH HHS R01 AI138901NIAID NIH HHS T32 AI007358NIMH NIH HHS T32 MH017119
6 · The paper itself

Abstract

Mechanistic network models specify the mechanisms by which networks grow and change, allowing researchers to investigate complex systems using both simulation and analytical techniques. Unfortunately, it is difficult to write likelihoods for instances of graphs generated with mechanistic models, and thus it is near impossible to estimate the parameters using maximum likelihood estimation. In this paper, we propose treating the node sequence in a growing network model as an additional parameter, or as a missing random variable, and maximizing over the resulting likelihood. We develop this framework in the context of a simple mechanistic network model, used to study gene duplication and divergence, and test a variety of algorithms for maximizing the likelihood in simulated graphs. We also run the best-performing algorithm on one human protein-protein interaction network and four nonhuman protein-protein interaction networks. Although we focus on a specific mechanistic network model, the proposed framework is more generally applicable to reversible models.

Indexed as

AlgorithmsProtein Interaction MapsComputer SimulationHumansLikelihood Functions

Identifiers

PMID37723718
PMCPMC10748807

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.